Total Payments
$6,056
2024 Payments
$604.61
Companies
30
Transactions
274
Medicare Patients
5,482
Medicare Billing
$643,880
Payment Breakdown by Category
Food & Beverage$5,891 (97.3%)
Travel$165.31 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,891 | 271 | 97.3% |
| Travel and Lodging | $165.31 | 3 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,038 | 46 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $707.36 | 40 | $0 (2024) |
| Abbott Laboratories | $472.37 | 14 | $0 (2021) |
| Amgen Inc. | $426.70 | 21 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $329.51 | 12 | $0 (2024) |
| BIOTRONIK INC. | $327.20 | 7 | $0 (2022) |
| Merck Sharp & Dohme LLC | $303.48 | 15 | $0 (2024) |
| Amarin Pharma Inc. | $280.50 | 14 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $279.66 | 11 | $0 (2024) |
| Boston Scientific Corporation | $266.94 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $604.61 | 26 | Kestra Medical Technology Services, Inc. ($124.75) |
| 2023 | $845.56 | 33 | Kestra Medical Technology Services, Inc. ($175.23) |
| 2022 | $1,263 | 51 | BIOTRONIK INC. ($327.20) |
| 2021 | $772.94 | 36 | Janssen Pharmaceuticals, Inc ($323.98) |
| 2020 | $576.39 | 28 | Janssen Pharmaceuticals, Inc ($193.31) |
| 2019 | $521.54 | 28 | Amgen Inc. ($149.75) |
| 2018 | $656.97 | 37 | Novartis Pharmaceuticals Corporation ($210.75) |
| 2017 | $815.09 | 35 | Abbott Laboratories ($322.67) |
All Payment Transactions
274 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| Category: Coronary | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $37.56 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $34.95 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.82 | General |
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: DIABETES | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/02/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.25 | General |
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: DIABETES | ||||||
| 06/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.52 | General |
| Category: Cardiovascular | ||||||
| 05/28/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.23 | General |
| 05/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 04/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: DIABETES | ||||||
| 02/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: DIABETES | ||||||
| 02/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Cardiology | ||||||
| 02/06/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $30.86 | General |
| Category: Cardiology | ||||||
| 02/06/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Cardiology | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,481 | 1,946 | $262,866 | $158,860 |
| 2022 | 24 | 1,027 | 1,379 | $182,450 | $115,721 |
| 2021 | 27 | 1,444 | 1,949 | $242,525 | $161,791 |
| 2020 | 27 | 1,530 | 1,930 | $309,429 | $207,509 |
Total Patients
5,482
Total Services
7,204
Medicare Billing
$643,880
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 99 | 99 | $59,400 | $41,385 | 69.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 222 | 396 | $49,475 | $29,489 | 59.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 138 | 143 | $39,325 | $22,732 | 57.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 81 | 83 | $20,750 | $14,583 | 70.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 98 | 196 | $9,296 | $6,751 | 72.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 64 | 64 | $8,960 | $6,258 | 69.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 101 | 101 | $10,100 | $5,477 | 54.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 24 | 24 | $8,400 | $5,132 | 61.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 23 | 23 | $6,325 | $3,983 | 63.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 62 | 62 | $10,230 | $3,912 | 38.2% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 65 | 66 | $9,900 | $3,682 | 37.2% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 27 | 27 | $6,210 | $2,640 | 42.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 161 | 212 | $5,300 | $2,552 | 48.2% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 15 | 15 | $4,125 | $2,030 | 49.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 24 | 24 | $2,400 | $1,299 | 54.1% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 24 | 24 | $1,800 | $1,141 | 63.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 11 | 17 | $1,700 | $1,093 | 64.3% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Office | 2023 | 21 | 21 | $1,470 | $917.80 | 62.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 24 | 24 | $1,920 | $878.16 | 45.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 101 | 104 | $1,040 | $873.60 | 84.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 20 | 20 | $2,000 | $825.40 | 41.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 31 | 32 | $1,600 | $690.06 | 43.1% |
| J1245 | Injection, dipyridamole, per 10 mg | Office | 2023 | 31 | 155 | $930.00 | $441.53 | 47.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 14 | 14 | $210.00 | $94.51 | 45.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 60 | 60 | $36,000 | $27,286 | 75.8% |
About Dr. Chaim Moeller, M.D
Dr. Chaim Moeller, M.D is a Clinical Cardiac Electrophysiology healthcare provider based in Kew Gardens, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1306016969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chaim Moeller, M.D has received a total of $6,056 in payments from pharmaceutical and medical device companies, with $604.61 received in 2024. These payments were reported across 274 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,891).
As a Medicare-enrolled provider, Moeller has provided services to 5,482 Medicare beneficiaries, totaling 7,204 services with total Medicare billing of $643,880. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Kew Gardens, NY
- Active Since 03/10/2008
- Last Updated 02/04/2021
- Taxonomy Code 207RC0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306016969
Products in Payments
- XARELTO (Drug) $1,038
- CardioMEMS HF System (Device) $428.52
- ENTRESTO (Drug) $408.65
- Assure WCD (Device) $329.51
- ELIQUIS (Drug) $307.31
- LEQVIO (Drug) $298.71
- Vascepa (Drug) $280.50
- VERQUVO (Drug) $269.67
- Corlanor (Drug) $224.22
- JARDIANCE (Drug) $223.39
- Repatha (Biological) $202.48
- LifeVest (Device) $167.28
- Impella (Device) $148.34
- Inpefa (Drug) $105.36
- PRALUENT ALIROCUMAB INJECTION (Biological) $99.94
- WATCHMAN (Device) $99.91
- Barostim Neo System (Device) $76.07
- XIFAXAN (Drug) $70.67
- LUX DX (Device) $61.80
- PRADAXA (Drug) $56.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.